Please select the option that best describes you:
Does the presence of a POLE mutation in endometrial cancer guide your recommendations regarding adjuvant radiation?
Answer from: Radiation Oncologist at Community Practice
It’s part of PORTEC 4 study to randomize patients to adjuvant RT based on molecular subtype. They are exploring if observation is suitable option for POLE type
Outside of a trial we still decide based on stage and grade for adjuvant treatment and not on molecular subtype.
Sign in or Register to read more